triple g retatrutide Lilly's Next Breakthrough: Triple-G Drug Delivers Stunning 29% Weight Loss Retatrutide Peptide | Triple Agonist

For a triple-receptor agonist that targets GLP-1 , GIP, and glucagon receptors simultaneously, the neurological ripple effects are still being studied, still being understood

19:13 The patient intake process and data-driven care 21:07 The science of sarcopenia and strength training 25:21 Why muscle is the most important longevity tool 27:12 Creatine, carbs, protein, and progressive overload 31:29 Kristins ideal lab panel for the average adult 33:56 Why hormones and stress are often at the root 35:37 GLP-1s: When they helpand when they harm 39:52 A placebo GLP-1 success story 42:13 Functional testing timelines and stool test insights 44:11 How high cortisol is misunderstood in fitness 47:52 The stress bucket analogy: Its not just HIIT 49:50 The importance of pregnenolone and cortisol rhythm 51:54 Scaling with integrity: new locations & private equity 53:26 How to maintain personalization while scaling 55:45 Team culture, retreats, and core values 58:42 Whats next: Baby #3, a book, and more growth 01:00:45 Little by little, a little becomes a lot 01:07:23 Rapid fire: Favorite labs, supplements, and metrics 01:13:14 How HRV guides Kristins clinical decisions 01:14:13 Final thoughts and where to find Kristin

[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Roy A, et al

Dose escalation followed a stepwise schedule, progressing from 2 mg up to a maximum of 12 mg once weekly over several months, depending on tolerability

Compounded semaglutide typically has a Beyond-Use Date (BUD) of 30 to 90 days, as determined by the compounding pharmacy

[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Rebbapragada A, Benchabane H, Wrana JL, et al